S-Clinica

S-Clinica

Leuven, Belgium· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

S-Clinica is a specialized provider of AI-driven clinical trial supply chain management software, headquartered in Leuven, Belgium. The company's integrated platform features a proprietary predictive probabilistic algorithm adjusted in real-time, working alongside a highly configurable RTSM system to help pharmaceutical and biotech sponsors minimize drug wastage, anticipate risks, and significantly reduce supply costs. While not developing therapeutics itself, S-Clinica serves as a critical enabler for complex clinical trials, including those in personalized medicine (cell & gene therapy, radiopharmaceuticals) and veterinary studies, with a claimed client base that includes top-tier pharmaceutical companies.

Digital HealthAI / Machine Learning

Technology Platform

Integrated software platform combining a predictive probabilistic supply forecasting algorithm (using Monte Carlo/Bayesian methods) with a highly configurable Randomization and Trial Supply Management (RTSM/IRT) system. Modules include Direct-to-Patient, Return & Destruction, and Veterinary trial support, all on a single database.

Opportunities

The shift towards complex, adaptive, and decentralized clinical trials, especially in personalized medicine (cell/gene therapy) and rare diseases, creates strong demand for intelligent supply chain solutions.
Expansion into adjacent regulated markets, such as veterinary clinical trials under new EU regulations, presents a clear growth avenue.

Risk Factors

Faces intense competition from larger, established clinical technology vendors and CROs.
Revenue is dependent on winning contracts with pharmaceutical sponsors, which involves long sales cycles and rigorous validation processes.
Must continuously ensure platform scalability and compliance with evolving global regulations.

Competitive Landscape

Competes against large clinical trial technology suites (e.g., Veeva Vault RTSM, Medidata Rave RTSM) and best-of-breed IRT vendors. Differentiation is based on its proprietary predictive forecasting algorithm, deep integration between planning and execution modules, and claimed flexibility for complex study designs. Its niche focus on supply chain intelligence is a key competitive positioning.